Munich — H&Z Unter­neh­mens­be­ra­tung AG advi­sed funds advi­sed by PREMIUM Equity Part­ners GmbH on the acqui­si­tion of a majo­rity stake in the Fila­Tech Group, Rema­gen­/R­hi­ne­land-Pala­ti­nate, during the commer­cial due diligence.

For more than 25 years, Fila­Tech has been the world’s leading inde­pen­dent system supplier of hollow fiber spin­ning systems that produce membrane fibers for the manu­fac­ture of dialy­zers used to wash the blood of kidney pati­ents. In view of the high growth rates of kidney dise­ase world­wide and the predo­mi­nant use of end-stage dialy­sis, there is a growing need for dialy­zers. Fila­Tech is also active in the produc­tion of gas sepa­ra­tion and water puri­fi­ca­tion systems, which are based on simi­lar prin­ci­ples for filter production.

The two senior mana­ging direc­tors and company foun­ders, Dr. Thomas Müller and Heinz Lands­berg, will remain on the manage­ment board for a tran­si­tio­nal period and then move to the company’s advi­sory board. — Toge­ther with the fami­lies invol­ved and the new CEO Robert de Deugd, PREMIUM will support the growth oppor­tu­ni­ties and promote both geogra­phi­cal diver­si­fi­ca­tion and the broa­de­ning of the product range.

Advi­sor PREMIUM Equity: H&Z

Dr. Markus Cont­zen (Part­ner M&A Advi­sory and Private Equity)
Sascha Taglia­ferri (Senior Project Mana­ger M&A Advi­sory and Private Equity)

www.hz.group